Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2020

Jan 19, 2021

BUY
$14.61 - $22.14 $1,461 - $2,214
100 Added 50.0%
300 $6,000
Q1 2020

May 04, 2020

BUY
$10.23 - $24.56 $1,023 - $2,456
100 Added 100.0%
200 $2,000
Q4 2019

Jan 31, 2020

BUY
$17.42 - $26.61 $1,742 - $2,661
100 New
100 $2,000

Others Institutions Holding HRTX

About HERON THERAPEUTICS, INC.


  • Ticker HRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 118,774,000
  • Market Cap $188M
  • Description
  • Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...
More about HRTX
Track This Portfolio

Track Congress Park Capital LLC Portfolio

Follow Congress Park Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Congress Park Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Congress Park Capital LLC with notifications on news.